9318 related articles for article (PubMed ID: 17373201)
1. A review of deferasirox, bortezomib, dasatinib, and cyclosporine eye drops: possible uses and known side effects in cutaneous medicine.
Scheinfeld N
J Drugs Dermatol; 2007 Mar; 6(3):352-5. PubMed ID: 17373201
[TBL] [Abstract][Full Text] [Related]
2. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
Steinberg M
Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
[TBL] [Abstract][Full Text] [Related]
3. Dasatinib: BMS 354825.
Drugs R D; 2006; 7(2):129-32. PubMed ID: 16542059
[TBL] [Abstract][Full Text] [Related]
4. Dasatinib, a multikinase inhibitor: therapy, safety, and appropriate management of adverse events.
Shayani S
Ther Drug Monit; 2010 Dec; 32(6):680-7. PubMed ID: 20864900
[TBL] [Abstract][Full Text] [Related]
5. New approved dasatinib regimen available for clinical use.
Snyder DS
Expert Rev Anticancer Ther; 2009 Mar; 9(3):285-92. PubMed ID: 19275507
[TBL] [Abstract][Full Text] [Related]
6. Use of dasatinib in the patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia with resistance to imatinib and renal failure.
Sonmez M; Cobanoglu U; Ovali E; Omay SB
J Clin Pharm Ther; 2008 Jun; 33(3):329-30. PubMed ID: 18452422
[No Abstract] [Full Text] [Related]
7. A comprehensive review of imatinib mesylate (Gleevec) for dermatological diseases.
Scheinfeld N
J Drugs Dermatol; 2006 Feb; 5(2):117-22. PubMed ID: 16485879
[TBL] [Abstract][Full Text] [Related]
8. Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias.
Talpaz M; Shah NP; Kantarjian H; Donato N; Nicoll J; Paquette R; Cortes J; O'Brien S; Nicaise C; Bleickardt E; Blackwood-Chirchir MA; Iyer V; Chen TT; Huang F; Decillis AP; Sawyers CL
N Engl J Med; 2006 Jun; 354(24):2531-41. PubMed ID: 16775234
[TBL] [Abstract][Full Text] [Related]
9. Imatinib mesylate and dermatology part 2: a review of the cutaneous side effects of imatinib mesylate.
Scheinfeld N
J Drugs Dermatol; 2006 Mar; 5(3):228-31. PubMed ID: 16573254
[TBL] [Abstract][Full Text] [Related]
10. [Dasatinib. A novel tyrosine kinase inhibitor for the treatment of chronic myeloid leukaemia].
Bjerrum OW; Dufva IH; Stentoft J; Hasselbalch HC
Ugeskr Laeger; 2008 Jan; 170(5):331-3. PubMed ID: 18252160
[TBL] [Abstract][Full Text] [Related]
11. Successful pregnancy involving a man with chronic myeloid leukemia on dasatinib.
Oweini H; Otrock ZK; Mahfouz RA; Bazarbachi A
Arch Gynecol Obstet; 2011 Jan; 283(1):133-4. PubMed ID: 20473616
[TBL] [Abstract][Full Text] [Related]
12. Transcriptomic rationale for the synergy observed with dasatinib + bortezomib + dexamethasone in multiple myeloma.
de Queiroz Crusoe E; Maiso P; Fernandez-Lazaro D; San-Segundo L; Garayoa M; Garcia-Gomez A; Gutierrez NC; Delgado M; Colado E; Martin-Sanchez J; Lee FY; Ocio EM
Ann Hematol; 2012 Feb; 91(2):257-69. PubMed ID: 21720745
[TBL] [Abstract][Full Text] [Related]
13. Pleomorphic presentation of cutaneous lesions associated with the proteasome inhibitor bortezomib in patients with multiple myeloma.
Wu KL; Heule F; Lam K; Sonneveld P
J Am Acad Dermatol; 2006 Nov; 55(5):897-900. PubMed ID: 17052502
[TBL] [Abstract][Full Text] [Related]
14. Deferasirox for porphyria cutanea tarda: a pilot study.
Pandya AG; Nezafati KA; Ashe-Randolph M; Yalamanchili R
Arch Dermatol; 2012 Aug; 148(8):898-901. PubMed ID: 22911183
[TBL] [Abstract][Full Text] [Related]
15. Dasatinib: for some difficult cases of adult leukaemia.
Prescrire Int; 2008 Aug; 17(96):149-50. PubMed ID: 19496239
[No Abstract] [Full Text] [Related]
16. Deferasirox (Exjade): a new iron chelator.
Med Lett Drugs Ther; 2006 Apr; 48(1233):35-6. PubMed ID: 16625144
[No Abstract] [Full Text] [Related]
17. Dasatinib as salvage therapy for steroid refractory and imatinib resistant or intolerant sclerotic chronic graft-versus-host disease.
Sánchez-Ortega I; Servitje O; Arnan M; Ortí G; Peralta T; Manresa F; Duarte RF
Biol Blood Marrow Transplant; 2012 Feb; 18(2):318-23. PubMed ID: 22068151
[TBL] [Abstract][Full Text] [Related]
18. Rectal bleeding and diarrhea caused by bortezomib-induced colitis.
Nogales Rincón O; Huerta Madrigal A; Merino Rodriguez B; González Asanza C; Cos Arregui E; Menchén Fernández-Pacheco P
Gastroenterol Hepatol; 2010 Dec; 33(10):753-4. PubMed ID: 20674097
[No Abstract] [Full Text] [Related]
19. [Recurrent neutrophilic panniculitis in a patient with chronic myelogenous leukaemia treated with imatinib mesilate and dasatinib].
de Masson A; Bouvresse S; Clérici T; Mahé E; Saïag P
Ann Dermatol Venereol; 2011 Feb; 138(2):135-9. PubMed ID: 21333826
[TBL] [Abstract][Full Text] [Related]
20. [Cyclosporine eye drops: A 4-year retrospective study (2009-2013)].
Kauss Hornecker M; Charles Weber S; Brandely Piat ML; Darrodes M; Jomaa K; Chast F
J Fr Ophtalmol; 2015 Oct; 38(8):700-8. PubMed ID: 26371985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
